TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
QuiaPEG Pharmaceuticals AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
|
216 |
Financial expenses |
25
|
55
|
194 |
Earnings before taxes |
-13,013
|
-13,561
|
-14,902 |
EBITDA |
-9,129
|
-10,138
|
-12,519 |
Total assets |
20,936
|
21,518
|
18,687 |
Current assets |
741
|
1,838
|
1,214 |
Current liabilities |
4,781
|
15,714
|
17,108 |
Equity capital |
16,155
|
5,748
|
1,209 |
- share capital |
154
![]() |
154
![]() |
154 |
Employees (average) |
3
|
4
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.2%
|
26.7%
|
6.5% |
Turnover per employee |
0
![]() |
0
|
43 |
Profit as a percentage of turnover | -6899.1% | ||
Return on assets (ROA) |
-62.0%
|
-62.8%
|
-78.7% |
Current ratio |
15.5%
|
11.7%
|
7.1% |
Return on equity (ROE) |
-80.6%
|
-235.9%
|
-1232.6% |
Change turnover |
0
|
-216
|
-1,645 |
Change turnover % |
-100%
|
-88% | |
Chg. No. of employees |
-1
![]() |
-1
|
2 |
Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.